Avantor, Inc. engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, and fluid handling tips. It also provides equipment and instrumentation products, including filtration systems, virus inactivation systems, incubators, analytical instruments, evaporators, ultra-low-temperature freezers, biological safety cabinets, peristaltic pumps, and critical environment supplies. In addition, the company offers services and specialty procurements comprising onsite lab and production, equipment, procurement and sourcing, and biopharmaceutical material scale-up and development services. Further, it provides scientific research support services, such as DNA extraction, bioreactor servicing, clinical and biorepository, compound management, cleanroom control, monitoring, maintenance, and sanitization services. The company was founded in 1904 and is headquartered in Radnor, Pennsylvania.
Lab Solutions Resilience | Explore Avantor's Lab Solutions segment, showing strength amidst broader challenges and positioning the company for potential future growth in life sciences |
Leadership Transition | Delve into the impact of CEO Michael Stubblefield's departure on Avantor's strategic direction and market perception amid ongoing industry pressures |
Margin Improvement Path | Learn about Avantor's ambitious goal of achieving a 20% EBITDA margin by 2025 through cost reduction initiatives and operational efficiencies |
Analyst Perspectives | Discover varied analyst views on Avantor's prospects, with price targets ranging from $15 to $33, reflecting both challenges and potential opportunities |
Metrics to compare | AVTR | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipAVTRPeersSector | |
---|---|---|---|---|
P/E Ratio | 13.2x | −0.5x | −0.6x | |
PEG Ratio | 0.14 | 0.01 | 0.00 | |
Price/Book | 1.4x | 0.8x | 2.6x | |
Price / LTM Sales | 1.4x | 1.9x | 3.3x | |
Upside (Analyst Target) | 5.5% | 137.5% | 38.0% | |
Fair Value Upside | Unlock | 34.1% | 4.4% | Unlock |